XML 46 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2017
Equity [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s stock option and SARs activities and related information for the year ended December 31, 2017, is as follows:

 

     Number of
options and
SAR
units (1)
     Weighted
average
exercise

price
     Weighted
average
remaining
contractual
term
     Aggregate
intrinsic-
value
 

Outstanding at the beginning of the year

     1,455,908      $ 19.76        

Granted

     —          —          

Exercised

     (711,208      19.80        

Forfeited or expired

     (15,683      17.51        
  

 

 

    

 

 

       

Outstanding at the end of the year (2)

     729,017      $ 19.77        5.2      $ 19,229  
  

 

 

    

 

 

    

 

 

    

 

 

 

Exercisable at the end of the year (3)

     513,464      $ 19.07        4.7      $ 13,906  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

  (1) The SAR units are convertible for a maximum number of shares of the Company’s common stock equal to 75% of the SAR units subject to the grant.

 

  (2) Due to the ceiling imposed on the SAR grants, the outstanding amount equals a maximum of 662,075 shares of the Company’s common stock issuable upon exercise.

 

  (3) Due to the ceiling imposed on the SAR grants, the exercisable amount equals a maximum of 465,223 shares of the Company’s common stock issuable upon exercise.
Schedule of Options Granted, Classified into Range of Exercise Price

The options and SARs granted to employees of the Company and its subsidiaries and the options granted to non-employee directors of the Company which were outstanding as of December 31, 2017 have been classified into a range of exercise prices as follows:

 

     Outstanding      Exercisable  

Exercise price

(range)

   Number
of

options
and SARs
     Weighted
average

remaining
contractual

life (years)
     Weighted
average

exercise
price
     Number
of

options
and SARs
     Weighted
average

remaining
contractual

life (years)
     Weighted
average

exercise
price
 

14.16-18.62

     365,793        4.2      $ 15.64        290,193        4.0      $ 15.80  

19.36-24.86

     204,724        5.9      $ 19.91        142,771        5.8      $ 19.65  

27.17-31.51

     158,500        6.9      $ 29.13        80,500        5.2      $ 29.81  
  

 

 

          

 

 

       
     729,017        5.2      $ 19.77        513,464        4.7      $ 19.07  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
Summary of Restricted Stock Units Activity

A summary of the Company’s RSU activities and related information for the year ended December 31, 2017, is as follows:

 

     Number of
RSUs
     Weighted
average
Grant-Date

fair value
 

Unvested as at the beginning of the year

     505,142      $ 21.59  

Granted

     288,197        37.25  

Vested

     (203,016      21.85  

Forfeited

     (29,707      26.07  
  

 

 

    

Unvested at the end of the year

     560,616      $ 29.31